Greenberg Traurig Shareholder Jim Prochnow is speaking on the panel "Traversing the Unique Legal Landscape Governing Homeopathic Products" at the American Conference Institute's Advanced Forum Conference on OTC Drugs in New York. This panel session will examine the implications of FDA’s December 2022 guidance for homeopathic products and the ongoing efforts and strategies employed by both the industry and FDA to ensure compliance and navigate the evolving regulatory landscape within this niche segment.